U.S. market Closed. Opens in 15 hours 38 minutes

DALS | DA32 Life Science Tech Acquisition Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-31
RevenueN/AN/A
Cost of RevenueN/AN/A
Gross ProfitN/AN/A
Operating Expenses1.76M365.96K
Selling, General & Admin1.56M365.96K
Research & DevelopmentN/AN/A
Other Operating Expenses200.05KN/A
Operating Income-1.76M-595.98K
Other Expenses / Income2.90M24.69K
Before Tax Income1.14M-571.29K
Income Tax Expenses542.67K-24.69K
Net Income599.22K-546.61K
Interest Expenses-2.90M-24.69K
Basic Shares Outstanding20.65M25.65M
Diluted Shares Outstanding20.65M25.65M
EBITDA-4.66M-571.29K
EBITDA Margin0.00%0.00%
EBIT-1.76M-595.98K
EBIT Margin0.00%0.00%
Financial Year End2022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙